Table 1 Patients’ on-study characteristics (N = 249)
From: Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors
Ethnicity | N | % |
|---|---|---|
Caucasian | 110 | 44.2 |
African American | 123 | 49.4 |
American Indian | 3 | 1.2 |
Hispanic | 3 | 1.2 |
Asian | 5 | 2.0 |
Other | 5 | 2.0 |
Age at diagnosis, years | ||
Median | 46 | |
Range | 25–64 | |
Gender | ||
Female | 249 | 100.0 |
Surgery | ||
Lumpectomy | 137 | 55.0 |
Mastectomy | 109 | 43.4 |
Unknown | 4 | 1.6 |
Chemotherapy | ||
Yes | 135 | 54.2 |
No | 97 | 39.0 |
Unknown | 17 | 6.8 |
Radiation | ||
Yes | 157 | 63.1 |
No | 78 | 31.3 |
Unknown | 14 | 5.6 |
Hormone therapy | ||
Yes | 152 | 61.0 |
No | 74 | 29.7 |
Unknown | 23 | 9.2 |
Stage | ||
0 | 50 | 20.1 |
1 | 84 | 33.7 |
2 | 69 | 27.7 |
3 | 39 | 15.7 |
Unknown | 7 | 2.8 |
ER | ||
ER− | 45 | 18.1 |
ER+ | 144 | 57.8 |
Unknown | 60 | 24.1 |
PR | ||
PR− | 60 | 24.1 |
PR+ | 119 | 47.8 |
Unknown | 70 | 28.1 |
HER2 | ||
HER2- | 103 | 41.4 |
HER2+ | 27 | 10.8 |
Unknown | 119 | 47.8 |